Cisplatin decreases renal cyclooxygenase-2 expression and activity in rats

Acta Physiologica

Volumn 202, Issue 1, 2011, Pages 79-90

  Tusgaard, B ^a,b   Norregaard R ^a   Jensen, A M ^a   Wang, G ^a   Topcu, S O ^a   Wang, Y ^a   Nielsen, S ^a   Frokiaer J ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Acute renal failure; AQP2; Cisplatin; COX 2; Na K 2Cl cotransporter; Prostaglandin E2

Indexed keywords

AQUAPORIN 2; CHLORINE; CISPLATIN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; MISOPROSTOL; POTASSIUM; SODIUM; SODIUM CHLORIDE;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; KIDNEY CORTEX; KIDNEY MEDULLA; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; POLYURIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT;

ACUTE KIDNEY INJURY; ANIMALS; ANTINEOPLASTIC AGENTS; AQUAPORIN 2; CISPLATIN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DINOPROSTONE; INTRAMOLECULAR OXIDOREDUCTASES; KIDNEY; KIDNEY FUNCTION TESTS; MALE; MISOPROSTOL; OXYTOCICS; RATS; RATS, WISTAR; SODIUM-POTASSIUM-CHLORIDE SYMPORTERS;

EID: 79953695643     PISSN: 17481708     EISSN: 17481716     Source Type: Journal    
DOI: 10.1111/j.1748-1716.2011.02257.x     Document Type: Article

References (41)

1. Al Suleimani, Y.M., Abdelrahman, A.M., Almahruqi, A.S., Alhseini, I.S., Tageldin, M.H. & Mansour, M.E. 2009. Interaction of nimesulide, a cyclooxygenase-2 inhibitor, with cisplatin in normotensive and spontaneously hypertensive rats. Food Chem Toxicol 48, 139-144.
2. Arany, I. & Safirstein, R.L. 2003. Cisplatin nephrotoxicity. Semin Nephrol 23, 460-464.
3. Bae, E.H., Lee, J., Ma, S.K., Kim, I.J., Frokiaer, J. & Nielsen, S. 2009. {alpha}-lipoic acid prevents cisplatin-induced acute kidney injury in rats. Nephrol Dial Transplant 24, 2692-2700.
4. Banijamali, H.S., ter Keurs, M.H., ter Keurs, H.E., Benediktsson, H. & Paul, L.C. 1998. Effect of misoprostol on myocardial contractility in rats treated with cyclosporin A. J Cardiovasc Pharmacol 32, 139-145.
5. Breyer, M.D. & Breyer, R.M. 2000. Prostaglandin E receptors and the kidney. Am J Physiol Renal Physiol 279, F12-F23.
6. Cheng, H.F. & Harris, R.C. 2002. Cyclooxygenase-2 expression in cultured cortical thick ascending limb of Henle increases in response to decreased extracellular ionic content by both transcriptional and post-transcriptional mechanisms. Role of p38-mediated pathways. J Biol Chem 277, 45638-45643.
7. Daugaard, G. 1990. Cisplatin nephrotoxicity: experimental and clinical studies. Dan Med Bull 37, 1-12.
8. Daugaard, G., Abildgaard, U., Holstein-Rathlou, N.H., Amtorp, O. & Leyssac, P.P. 1987. Effect of cisplatin on renal haemodynamics and tubular function in the dog kidney. Int J Androl 10, 347-351.
9. Davies, C., Forrester, S.D., Troy, G.C., Saunders, G.K., Shell, L.G. & Johnston, S.A. 1998. Effects of a prostaglandin E1 analogue, misoprostol, on renal function in dogs receiving nephrotoxic doses of gentamicin. Am J Vet Res 59, 1048-1054.
10. Deng, J., Kohda, Y., Chiao, H., Wang, Y., Hu, X. & Hewitt, S.M. 2001. Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injury. Kidney Int 60, 2118-2128.
11. DiGiovanni, S.R., Nielsen, S., Christensen, E.I. & Knepper, M.A. 1994. Regulation of collecting duct water channel expression by vasopressin in Brattleboro rat. Proc Natl Acad Sci USA 91, 8984-8988.
12. Ecelbarger, C.A., Terris, J., Hoyer, J.R., Nielsen, S., Wade, J.B. & Knepper, M.A. 1996. Localization and regulation of the rat renal Na(+)-K(+)-2Cl- cotransporter, BSC-1. Am J Physiol 271, F619-F628.
13. Ecelbarger, C.A., Sands, J.M., Doran, J.J., Cacini, W. & Kishore, B.K. 2001. Expression of salt and urea transporters in rat kidney during cisplatin-induced polyuria. Kidney Int 60, 2274-2282.
14. Gordon, J.A., Peterson, L.N. & Anderson, R.J. 1982. Water metabolism after cisplatin in the rat. Am J Physiol 243, F36-F43.
15. Hao, C.M. & Breyer, M.D. 2007. Physiologic and pathophysiologic roles of lipid mediators in the kidney. Kidney Int 71, 1105-1115.
16. Harris, R.C. 2000. Cyclooxygenase-2 in the kidney. J Am Soc Nephrol 11, 2387-2394.
17. Harris, R.C. 2006. COX-2 and the kidney. J Cardiovasc Pharmacol 47(Suppl.1), S37-S42.
18. Harris, R.C. 2008. An update on cyclooxygenase-2 expression and metabolites in the kidney. Curr Opin Nephrol Hypertens 17, 64-69.
19. Harris, R.C. & Breyer, M.D. 2001. Physiological regulation of cyclooxygenase-2 in the kidney. Am J Physiol Renal Physiol 281, F1-F11.
20. Ikeguchi, M., Maeta, M. & Kaibara, N. 2000. Cisplatin combined with prostaglandin E1 chemotherapy in rat peritoneal carcinomatosis. Int J Cancer 88, 474-478.
21. Jia, Z., Wang, N., Aoyagi, T., Wang, H., Liu, H. & Yang, T.. 2011. Amelioration of cisplatin nephrotoxicity by genetic or pharmacologic blockade of prostaglandin synthesis. Kidney Int 1, 1429-1431.
22. John, E.G., Fornell, L.C., Radhakrishnan, J., Anutrakulchai, S. & Jonasson, O. 1993. The effect of prostaglandin E1 analog misoprostol on chronic cyclosporin nephrotoxicity. J Pediatr Surg 28, 1429-1431. Discussion 1432.
23. Kim, S.W., Lee, J.U., Nah, M.Y., Kang, D.G., Ahn, K.Y. & Lee, H.Sl. 2001. Cisplatin decreases the abundance of aquaporin water channels in rat kidney. J Am Soc Nephrol 12, 875-882.
24. Kishore, B.K., Krane, C.M., Di, I.D., Menon, A.G. & Cacini, W. 2000. Expression of renal aquaporins 1, 2, and 3 in a rat model of cisplatin-induced polyuria. Kidney Int 58, 701-711.
25. Kotnik, P., Nielsen, J., Kwon, T.H., Krisinik, C., Frokiaer, J. & Nielsen, S. 2005. Altered expression of COX-1, COX-2 and mPGES in rats with nephrogenic and central diabetes insipidus. Am J Physiol Renal Physiol 288, 1053-1068.
26. Lajer, H., Kristensen, M., Hansen, H.H., Nielsen, S., Frokiaer, J., Ostergaard, L.F., Christensen, S., Daugaard, G. & Jonassen, T.E. 2005. Magnesium depletion enhances cisplatin-induced nephrotoxicity. Cancer Chemother Pharmacol 56, 535-542.
27. Li, G., Sha, S.H., Zotova, E., Arezzo, J., Van de, W.T. & Schacht, J. 2002. Salicylate protects hearing and kidney function from cisplatin toxicity without compromising its oncolytic action. Lab Invest 82, 585-596.
28. Nielsen, S., Frokiaer, J., Marples, D., Kwon, T.H., Agre, P. & Knepper, M.A. 2002. Aquaporins in the kidney: from molecules to medicine. Physiol Rev 82, 205-244.
29. Norregaard, R., Jensen, B.L., Li, C., Wang, W., Knepper, M.A. & Nielsen, S. 2005. COX-2 inhibition prevents downregulation of key renal water and sodium transport proteins in response to bilateral ureteral obstruction. Am J Physiol Renal Physiol 289, F322-F333.
30. Ramesh, G. & Reeves, W.B. 2002. TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J Clin Invest 110, 835-842.
31. Ramesh, G. & Reeves, W.B. 2004. Inflammatory cytokines in acute renal failure. Kidney Int Suppl 91, S56-S61.
32. Safirstein, R., Miller, P., Dikman, S., Lyman, N. & Shapiro, C. 1981. Cisplatin nephrotoxicity in rats: defect in papillary hypertonicity. Am J Physiol 241, F175-F185.
33. Safirstein, R., Winston, J., Goldstein, M., Moel, D., Dikman, S. & Guttenplan, J. 1986. Cisplatin nephrotoxicity. Am J Kidney Dis 8, 356-367.
34. Schnermann, J. 1998. Juxtaglomerular cell complex in the regulation of renal salt excretion. Am J Physiol 274, R263-R279.
35. Villanueva, S., Cespedes, C., Gonzalez, A.A., Vio, C.P. & Velarde, V. 2007. Effect of ischemic acute renal damage on the expression of COX-2 and oxidative stress-related elements in rat kidney. Am J Physiol Renal Physiol 292, F1364-F1371.
36. Vukicevic, S., Simic, P., Borovecki, F., Grgurevic, L., Rogic, D. & Orlic, I. 2006. Role of EP2 and EP4 receptor-selective agonists of prostaglandin E(2) in acute and chronic kidney failure. Kidney Int 70, 1099-1106.
37. Wang, J.L., Cheng, H.F., Zhang, M.Z., McKanna, J.A. & Harris, R.C. 1998. Selective increase of cyclooxygenase-2 expression in a model of renal ablation. Am J Physiol 275, F613-F622.
38. Wang, J.L., Cheng, H.F. & Harris, R.C. 1999. Cyclooxygenase-2 inhibition decreases renin content and lowers blood pressure in a model of renovascular hypertension. Hypertension 34, 96-101.
39. Winston, J.A. & Safirstein, R. 1985. Reduced renal blood flow in early cisplatin-induced acute renal failure in the rat. Am J Physiol 249, F490-F496.
40. Yamamoto, E., Izawa, T., Juniantito, V., Kuwamura, M., Sugiura, K., Takeuchi, T. & Yamate, J. 2010. Involvement of endogenous prostaglandin E2 in tubular epithelial regeneration through inhibition of apoptosis and epithelial-mesenchymal transition in cisplatin-induced rat renal lesions. Histol Histopathol 25, 995-1007.
41. Zhang, B., Ramesh, G., Norbury, C.C. & Reeves, W.B. 2007. Cisplatin-induced nephrotoxicity is mediated by tumor necrosis factor-alpha produced by renal parenchymal cells. Kidney Int 2007 72, 37-44.